Enterprise Together with KSC
gene1on1
Finland
Company Overview
Consultation on lifestyle habits to increase the diversity of beneficial bacteria of the gut microorganisms and stabilize the balance of the bacteria through analyzing the genes of gut microorganisms
Sectors
- Digital Health - Microbiome
Project Summary
- Expert collective intelligence deep learning-based lifestyle medicine platform
Business Model
- Revenue model Health consulting fee and product sales fee based on microbiome analysis
- Key Customer Public/ Life insurance company where customer health management is important
Major Performance
-
Sales
- N/A
-
Investment
- USD 200K (CNTTech, ActnerLAB, Futureplay etc.)
-
Employees
- (2019) 3, (2020) 9
-
Patent
- 4 Registration, 4 Application
Overseas Expansion
Stage
Preparing for overseas expansion, and entering overseas markets
Status
Market research in Zurich, Switzerland
Performance
N/A
Products / Services
1
2
- Target Country
- Finland
- Date of Establishment
- Jul 17, 2019
-
- gene1on1@gene1on1. com gene1on1@gene1on1. com
-
- Website
- www.gene1on1.com www.gene1on1.com
-
- Location
- Nonhyeon-ro 98-gil, Gangnam-gu, Seoul, Republic of Korea
-
- CEO
- Jin Young Lee
-
- Founder’s Background
-
- Zephyr Innovation, CEO (2015~2018)
- Global Stem Cell/Regeneratvie Medicine R&D Promotion Center General Manager (2013~2014)
- Hallymn University School of Medicine, Master of Pharmacology (2004~2006)